RAB32 and cholangiocarcinoma: Our analysis of RAB32 expression across various cancers and their corresponding normal tissues, utilizing the TIMER2.0 database, revealed a notable increase in RAB32 expression levels in diverse types of cancers such as cholangiocarcinoma (CHOL), GBM, and renal clear cell carcinoma (KIRC) (Figure 1A).